Linked Life Data

16931204

Source:http://linkedlifedata.com/resource/pubmed/id/16931204

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2006-8-25
pubmed:abstractText
A 19-year old patient with tuberous sclerosis presented with a renal angiomyolipoma. Because animal trials of tuberous sclerosis showed an effect of rapamycin on renal tumors, our patient was administered rapamycin for 6 months. During this time, the renal angiomyolipoma shrank significantly, regrew during an 8-month period, and decreased in size again after readministration of rapamycin.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1523-6838
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
48
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
e27-9
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Antitumoral activity of rapamycin in renal angiomyolipoma associated with tuberous sclerosis complex.
pubmed:affiliation
Department of Dermatology, Tuberous Sclerosis Center, Ludwig-Maximilian-University Munich, Gemany. ralf.wienecke@med.uni-muenchen.de
pubmed:publicationType
Journal Article, Case Reports, Research Support, Non-U.S. Gov't